Resistance to rifampicin: a review (Q38239459)

31 August 2017

Resistance to rifampicin: a review (English)

1 reference

31 August 2017

1 reference

Beth P Goldstein

1

1 reference

31 August 2017

13 August 2014

1 reference

The Journal of Antibiotics

31 August 2017

1 reference

31 August 2017

67

1 reference

31 August 2017

9

1 reference

31 August 2017

625-630

1 reference

https://scigraph.springernature.com/pub.10.1038/ja.2014.107

31 August 2017

0 references

cites work

Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Rifampicin compared with penicllin in the treatment of gonorrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

The effect of rifampin on the nasopharyngeal carriage of Neisseria meningitidis in a military population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Interaction of rifamycin with bacterial RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Bacillus subtilis mutant altered in spore morphology and in RNA polymerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Mapping and sequencing of mutations in the Escherichia colirpoB gene that lead to rifampicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

The Primary Structure of Escherichia coli RNA Polymerase. Nucleotide Sequence of the rpoB Gene and Amino-Acid Sequence of the beta-Subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Amino acid changes in conserved regions of the beta-subunit of Escherichia coli RNA polymerase alter transcription pausing and termination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Structure of Escherichia coli RNA polymerase holoenzyme at last

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Structural perspective on mutations affecting the function of multisubunit RNA polymerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Molecular basis of rifampin resistance in Mycobacterium leprae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Characterization of rifampin-resistance in pathogenic mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Biological cost of rifampin resistance from the perspective of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Molecular characterization of rifampin-resistant Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Molecular basis of rifampicin resistance in Haemophilus influenzae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Mutations of the rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

A balancing act: efflux/influx in mycobacterial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Natural rifampin resistance in Treponema spp. correlates with presence of N531 in RpoB rif cluster i

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Mechanism of natural rifampin resistance of Streptomyces spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Activation of dormant bacterial genes by Nonomuraea sp. strain ATCC 39727 mutant-type RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Initiation of transcription in vitro is inhibited by lipiarmycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Streptolydigin-resistant mutants in an evolutionarily conserved region of the beta' subunit of Escherichia coli RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Streptolydigin resistance can be conferred by alterations to either the beta or beta' subunits of Bacillus subtilis RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Effects of rifampicin resistant rpoB mutations on antitermination and interaction with nusA in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like "stringent" RNA polymerases in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

A rifampicin resistent rna-polymerase from E. coli altered in the beta-subunit

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Reconstitution of bacterial DNA-dependent RNA-polymerase from isolated subunits as a tool for the elucidation of the role of the subunits in transcription

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the β subunit gene of the rifampicin resistant rpoB255 mutant

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Genetic analysis of Staphylococcus aureus RNA polymerase mutants

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Characterization of mutations in the rpoB gene in naturally rifampin-resistant Rickettsia species.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Integron-mediated rifampin resistance in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Resistance of Escherichia coli to rifampicin and sorangicin A - a comparison

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Rifampin resistance mutations that alter the efficiency of transcription termination at the tryptophan operon attenuator

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Altered nutritional requirements associated with mutations affecting the structures of ribonucleic acid polymerase in Lactobacillus casei

1 reference

https://api.crossref.org/works/10.1038%2FJA.2014.107

7 January 2021

Identifiers

DOI

10.1038/JA.2014.107

1 reference

PubMed ID

25118103

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

25118103